Rise Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-83
| Closed | -$2.1K | – | 1510 |
|
|
2024
Q4 | $2.1K | Hold |
83
| – | – | ﹤0.01% | 1072 |
|
|
2024
Q3 | $2.82K | Hold |
83
| – | – | ﹤0.01% | 1109 |
|
|
2024
Q2 | $3.07K | Hold |
83
| – | – | ﹤0.01% | 1100 |
|
|
2024
Q1 | $3.48K | Hold |
83
| – | – | ﹤0.01% | 1109 |
|
|
2023
Q4 | $3.29K | Hold |
83
| – | – | ﹤0.01% | 421 |
|
|
2023
Q3 | $2.28K | Hold |
83
| – | – | ﹤0.01% | 450 |
|
|
2023
Q2 | $2.82K | Hold |
83
| – | – | ﹤0.01% | 479 |
|
|
2023
Q1 | $2.99K | Hold |
83
| – | – | ﹤0.01% | 521 |
|
|
2022
Q4 | $3.7K | Hold |
83
| – | – | ﹤0.01% | 485 |
|
|
2022
Q3 | $2K | Hold |
83
| – | – | ﹤0.01% | 536 |
|
|
2022
Q2 | $2K | Hold |
83
| – | – | ﹤0.01% | 541 |
|
|
2022
Q1 | $3K | Hold |
83
| – | – | ﹤0.01% | 473 |
|
|
2021
Q4 | $3.21K | Buy |
+83
| New | +$3.21K | ﹤0.01% | 463 |
|